203
Views
5
CrossRef citations to date
0
Altmetric
Original Article: Research

Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin–transferrin conjugate in human leukemia cell lines

, &
Pages 1475-1483 | Received 05 Mar 2014, Accepted 09 Aug 2014, Published online: 27 Oct 2014

References

  • Castro L, Freeman BA. Reactive oxygen species in human health and disease. Nutrition 2001;17:161–165.
  • Casey TM, Arthur PG, Bogoyevitch MA. Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress. Biochim Biophys Acta 2007;3:342–351.
  • Chularojmontri L, Wattanapitayakul SK, Herunsalee A, et al. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol Pharm Bull 2005;28: 1165–1171.
  • Kalivendi SV, Kotamraju S, Zhao H, et al. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Biol Chem 2001;14:47266–47276.
  • Pieniążek A, Czepas J, Piasecka-Zelga J, et al. Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel. Adv Med Sci 2013;58:104–111.
  • Talati R, Vanderpoel A, Eladdadi A, et al. Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cells. Methods 2014;66: 139–152.
  • Lubgan D, Jóźwiak Z, Grabenbauer GG, et al. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 2009;14:113–127.
  • Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688–701.
  • Pasut G, Veronese FM. Polymer-drug conjugation, recent achievements and general strategies. Prog Polym Sci 2007;32: 933–961.
  • Seymour LW, Ferry DR, Kerr DJ, et al. Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. Int J Oncol 2009;34:1629–1636.
  • Pasut G, Greco F, Mero A, et al. Polymer-drug conjugates for combination anticancer therapy: investigating the mechanism of action. J Med Chem 2009;22:6499–6502.
  • Szwed M, Matusiak A, Laroche-Clary A, et al. Transferrin as a drug carrier: cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Toxicol In Vitro 2014;28:187–197.
  • Gervasoni JE, Hindenburg A, Vezeridis M, et al. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. Anticancer Res 2004;24:2617–2626.
  • Antunes F, Cadenas E, Brunk UT. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem J 2001;356:549–555.
  • Rogalska A, Koceva-Chyła A, Jóźwiak Z. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines. Chem Biol Interact 2008;176:58–70.
  • Tsang WP, Chau SP, Kong SK, et al. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 2003;73:2047–2058.
  • Berczi A, Ruthner M, Szuts V, et al. Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor-mediated endocytosis. Eur J Biochem 1993;213:427–436.
  • Kosmider B, Zyner E, Osiecka R, et al. Induction of apoptosis and necrosis in A549 cells by the cis-Pt (II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 2004;12:61–70.
  • Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005;11:127–152.
  • Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–77.
  • Levine RL, Wehr N, Williams JA, et al. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 2000;99:15–24.
  • Gay C, Gebicki JM, A critical evaluation of the effect of sorbitol on the ferric-xylenol orange hydroperoxide assay. Anal Biochem 2000;284:217–220.
  • Lowry OH, Rosebrough NG, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275.
  • Dotan Y, Lichtenberg D, Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 2004;43:200–227.
  • Wang Y, Wei X, Zhang C, et al. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Ther Deliv 2010;2:273–287.
  • Zhang X, Chibli H, Mielke R, et al. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells. Bioconjugate Chem 2011;16:235–243.
  • Luck AN, Mason AB. Structure and dynamics of drug carriers and their interaction with cellular receptors: focus on serum transferrin. Adv Drug Deliv Rev 2013;65:1012–1019.
  • Schatzlein AG, Rutherford C, Corrihons F, et al. Phage derived peptides for targeting of doxorubicin conjugates to solid tumours. J Control Release 2001;6:357–362.
  • Minotti G, Menna P, Salvatorelli E, et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185–229.
  • Simunek T, Stérba M, Popelová O, et al. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 2009;61:154–171.
  • Bartosz G. Druga twarz tlenu. Wolne rodniki w przyrodzie. In: Mechanizmy obrony, Vol. 2. Warszawa: Wydawnictwo Naukowe PWN; 2008. pp 145–179.
  • Maulik N, Das DK. Redox signaling in vascular angiogenesis. Free Rad Biol Med 2002;33:1047–1060.
  • Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antiox Redox Signal 2003;5:781–788.
  • Arunachalam S, Kim SY, Lee SH, et al. Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo. J Nat Med 2012;66:149–157.
  • Rogalska A, Gajek A, Szwed M, et al. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin. Toxicology In Vitro 2011;25:1712–1720.
  • Kayaaltı Z, Kaya D, Bacaksız A, et al. An association between polymorphism of the NADH/NADPH oxidase p22phox (phagocyte oxidase) subunit and aging in Turkish population. Aging Clin Exp Res 2013;25:511–516.
  • Munoz-Castaneda JR, Muntane J, Munoz MC, et al. Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol Lett 2006;160:196–203.
  • Tabaczar S, Koceva-Chyła A, Czepas J, et al. Nitroxide pirolin reduces oxidative stress generated by doxorubicin and docetaxel in blood plasma of rats bearing mammary tumor. J Physiol Pharmacol 2012;63:153–163.
  • Stěrba M, Popelová O, Vávrová A, et al. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antiox Redox Signal 2013;10: 899–929.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.